News About: Pharm. Industry
Enormous financial damages in the domestic pharmaceutical industry due to MERS, estimated at KRW 250 billion per month
Due to the impact of patient reduction in medical institutions, influenced by the MERS spread, it is required to plan our measure to handle the situation as various damages have been generated as pharmaceutical compan...
Zuellig Pharma Korea established the distribution service contract with Roche Korea
Zuellig Pharma Korea Ltd.(President Christophe Piganiol) announced that it established the agency and distribution service contract with Roche Korea(President Mike Crichton) and would start the service from 1 July.
U...
While the CDC increased 65% of its employees, the number of staffs in the KCDC decreased 12% down
What could possibly be happened to the Korea Centers for Disease Control and Prevention(KCDC), an organization established to combine functions of the United States Centers for Disease Control and Prevention(CDC) and ...
GSK will release about 100 employeesGSK will downsize the number of staffs again in 3 years. This is the 3rd reorganization in the past 5 years.
According to the industry concerned on the 24th, GSK will conduct t...
|
In the political situation with the MERS crisis, the ‘International Vaccine Institute’ appointed a new Korean secretary general, Jerome H. Kim
On the 22nd, the International Vaccine Institute(hereinafter referring to IVI) held the inauguration of the new secretary general, Jerome H. Kim(Korean name: Han-sik Kim) at the IVI headquarters in the Seoul National ...
Takeda Pharmaceuticals Korea is approved for its crohn’s disease treatment, ‘Kinteles Inj.’ from the Ministry of Health and WelfareTakeda Pharmaceuticals Korea (President Choon-yup Lee) announced that it has acquired an approval for its ulcerative colitis(UC) and crohn’s disease(CD) treatment, Kinteles Inj....
|
The Boryung Pharmaceutical’s Kanarb made a clinical procedure with the PMDA to challenge the Japanese marketBoryung Pharmaceutical (President Tae-hong Choi) took the first step to expand to Japan by holding a meeting to make a clinical procedure for an approval of Kanarb on the 19th w...
|
Ilyang Pharmaceutical signed the Term Sheet with a Mexican pharmaceutical company for NoltecIlyang Pharmaceutical (President Dong-yeon Kim) will export the 14th domestic new drug, “Noltec (generic name: ilaprazole),” to a Mexican company, “Chinoin Ing.(CEO Vincente Sar...
|
The compensation of Hanmi over violating the patent is judged to be KRW 10 million… “Got a minute to breath”
The court ruled Hanmi Pharm, which violated the patent related to the schizophrenia treatment, Zyprexa, to compensate KRW 10 million.
Since it was a judgment which did not accept the damage caused by the price reduct...
The world pays attention to the successful case of the Ilyang Pharmaceutical’s leukemia treatment ‘Supect’The successful case of the leukemia treatment, the domestically-developed new drug developed by Ilyang Pharmaceutical, ‘Supect,’ was introduced as the representative role model ...
|
